Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11085756 | PMC |
http://dx.doi.org/10.1136/bcr-2023-259227 | DOI Listing |
Am J Ophthalmol
December 2024
Department of Ophthalmology (O.N.K., M.S.H., L.L., Y.S., A.K.W., S.H., S.H.), Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine (O.N.K., M.S.H., L.L., A.K.W., S.H., L.T., S.H.), University of Copenhagen, Copenhagen, Denmark.
Purpose: To determine if paracentral acute middle maculopathy (PAMM) and peripapillary intraretinal and subretinal fluid (IRF/SRF) could help distinguish between arteritic anterior ischemic optic neuropathy (A-AION) and nonarteritic AION (NA-AION) at an early stage.
Design: Nested prospective cross-sectional diagnostic accuracy study.
Methods: This study used single-center optical coherence tomography (OCT) data from 8 patients with A-AION and 24 patients with NA-AION from two prospective cross-sectional studies with consecutive sampling (ClinicalTrials.
Front Immunol
November 2024
Senior Department of Ophthalmology, the Third Medical Center of Chinese People's Liberation Army (PLA) General Hospital & Chinese PLA Medical School, Beijing, China.
Background: Bilateral optic neuritis associated with optic disc swelling is a common feature of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). However, extensive deep retinal haemorrhages have not been described in the context of MOG-associated optic neuritis. Here, we report a case of infectious mononucleosis with marked binocular peripapillary and perivascular haemorrhages as well as extensive deep retinal haemorrhages in the presence of MOGAD.
View Article and Find Full Text PDFInt Ophthalmol
June 2024
Department of Ophthalmology, Faculty of Medicine, PortSaid University, PortSaid, Egypt.
BMC Ophthalmol
May 2024
Dept. of Retina and Vitreous, Narayana Nethralaya, #121/C, 1st R Block, Chord Road, Rajaji Nagar, Bengaluru, 560010, India.
Background: Macular retinoschisis (MRS) and myopic macular neovascularization (mMNV) are both potentially blinding complications of high myopia. In this case report, we highlight the progression of MRS after intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for mMNV, as well as an extensive review of the literature on this topic.
Case Description: A 49-year-old woman presented with two weeks of recent onset blurring and metamorphopsia in her right eye.
BMJ Case Rep
May 2024
Vitreoretina, Narayana Nethralaya, Bangalore, India
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!